Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
Journal of Nuclear Medicine · 2025-01 · 66 (1) · 98-103
DOI: 10.2967/jnumed.124.268376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 03.01.2025. Verfasst von Peng Hou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fibrosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study was to investigate the feasibility of using 18F-labeled fibroblast activation protein inhibitor (FAPI) PET/CT in assessing the fibrotic remodeling of the pulmonary artery (PA) and the right ventricle (RV) in pulmonary arterial hypertension (PAH).
Methods
In a rat model of monocrotaline-induced PAH, rats were euthanized at different time points for tissue analysis (fibroblast activation protein immunofluorescence and Masson's trichrome staining) after completing 18F-FAPI PET/CT and hemodynamic measurements. Thirty-eight PAH patients were enrolled to participate in 18F-FAPI PET/CT imaging, with right heart catheterization and echocardiography performed within 1 wk to assess pulmonary hemodynamics and cardiac function.
Results
In the animal experiments, RV systolic pressure in monocrotaline rats increased from day 14 to day 21 after injection. 18F-FAPI uptake and fibroblast activation protein expression in the myocardium and lungs peaked on day 14 after injection. Collagen deposition in the RVs and peripheral PAs of monocrotaline rats progressively deteriorated from day 14 to day 21. In the human PAH study, 18F-FAPI PET/CT imaging identified varying degrees of 18F-FAPI uptake in the myocardium and proximal and distal PAs, correlating with clinical, RV function, and pulmonary hemodynamic parameters. Among the 5 follow-up patients who underwent a second 18F-FAPI PET/CT scan after 6 mo (range, 4-9 mo) of PAH-targeted therapy, 3 demonstrated reduced 18F-FAPI uptake, corresponding with clinical improvement.
Conclusion
18F-FAPI PET/CT imaging is feasible for visualizing the remodeling of the PA and the RV in PAH. Although it offers promise for assessing disease-related changes, its role in evaluating disease severity and monitoring therapeutic efficacy requires further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Re…
- Department of Critical Care Medicine, Heyuan People's Hospital, Heyuan, China.
- Department of Nuclear Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; gyfyyhc@126.com 71lu@163.com.
Zitieren
APA
Hou, P., Chen, H., Liang, S., Guo, W., Zhao, R., Pan, H., Liu, H., Li, Y., Lv, J., Zhong, K., Ke, M., Fu, Y., Zhong, H., Wang, X., & Hong, C. (2025). Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension. Journal of Nuclear Medicine, 66(1), 98-103. https://doi.org/10.2967/jnumed.124.268376
Vancouver
Hou P, Chen H, Liang S, Guo W, Zhao R, Pan H, et al. Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension. Journal of Nuclear Medicine. 2025;66(1):98-103. doi:10.2967/jnumed.124.268376
BibTeX
@article{Hou2025,
author = {Hou, Peng and Chen, Haiming and Liang, Sihao and Guo, Wenliang and Zhao, Ruiyue and Pan, Huailu and Liu, Haimin and Li, Youcai and Lv, Jie and Zhong, Kaixiang and Ke, Miao and Fu, Yimin and Zhong, Huizhen and Wang, Xinlu and Hong, Cheng},
title = {Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension},
journal = {Journal of Nuclear Medicine},
year = {2025},
volume = {66},
number = {1},
pages = {98--103},
doi = {10.2967/jnumed.124.268376}
}
EUVIMED